Association of PH-Targeted Therapy and Survival in Precapillary PH with mPAP between 21 and 24 mmHg
PH-targeted therapy may be associated with improved survival in PAH and CTEPH patients with mild PH. To mitigate potential bias of the results due to the retrospective study design, randomised controlled trials are warranted.
Authors
- Luke Howard (ORCID: https://orcid.org/0000-0003-2822-210X)
- Joanna Pepke‐Żaba (ORCID: https://orcid.org/0000-0003-3764-3563)
- David Gerard Kiely (ORCID: https://orcid.org/0000-0003-0184-6502)
- Werner Seeger (ORCID: https://orcid.org/0000-0003-1946-0894)
- Paul M. Hassoun (ORCID: https://orcid.org/0000-0003-0601-4975)
- Aparna Balasubramanian (ORCID: https://orcid.org/0000-0002-1854-6672)
- Horst Olschewski (ORCID: https://orcid.org/0000-0002-2834-7466)
- Khodr Tello (ORCID: https://orcid.org/0000-0002-5557-623X)
- Allan Lawrie (ORCID: https://orcid.org/0000-0003-4192-9505)
- Meike Fünderich (ORCID: https://orcid.org/0009-0004-5457-9836)
- Athiththan Yogeswaran (ORCID: https://orcid.org/0000-0001-9505-8608)
- Hossein Ardeschir Ghofrani (ORCID: https://orcid.org/0000-0002-2029-4419)
- Friedrich Grimminger (ORCID: https://orcid.org/0000-0001-8725-6276)
- Martin R. Wilkins (ORCID: https://orcid.org/0000-0003-3926-1171)
- Gábor Kovács (ORCID: https://orcid.org/0000-0003-3709-2183)
- Ziad Konswa
- John Cannon
Institutions
- Johns Hopkins University (US)
- Imperial College Healthcare NHS Trust (GB)
- Royal Papworth Hospital (GB)
- Johns Hopkins Medicine (US)
- Royal Hallamshire Hospital (GB)
- Graz University Hospital (AT)
- Universities of Giessen and Marburg Lung Center (DE)
- Kerckhoff Klinik (DE)
- Cardio-Pulmonary Institute (DE)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1183/23120541.00466-2024
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cardiovascular Medical Research and Education Fund